2018 FDA Tides Harvest

In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and econ...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Shaer, Danah, Al Musaimi, Othman, Albericio, Fernando, de la Torre, Beatriz G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631726/
https://www.ncbi.nlm.nih.gov/pubmed/30959752
http://dx.doi.org/10.3390/ph12020052
_version_ 1783435585565753344
author Al Shaer, Danah
Al Musaimi, Othman
Albericio, Fernando
de la Torre, Beatriz G.
author_facet Al Shaer, Danah
Al Musaimi, Othman
Albericio, Fernando
de la Torre, Beatriz G.
author_sort Al Shaer, Danah
collection PubMed
description In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
format Online
Article
Text
id pubmed-6631726
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66317262019-08-19 2018 FDA Tides Harvest Al Shaer, Danah Al Musaimi, Othman Albericio, Fernando de la Torre, Beatriz G. Pharmaceuticals (Basel) Review In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics. MDPI 2019-04-05 /pmc/articles/PMC6631726/ /pubmed/30959752 http://dx.doi.org/10.3390/ph12020052 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Al Shaer, Danah
Al Musaimi, Othman
Albericio, Fernando
de la Torre, Beatriz G.
2018 FDA Tides Harvest
title 2018 FDA Tides Harvest
title_full 2018 FDA Tides Harvest
title_fullStr 2018 FDA Tides Harvest
title_full_unstemmed 2018 FDA Tides Harvest
title_short 2018 FDA Tides Harvest
title_sort 2018 fda tides harvest
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631726/
https://www.ncbi.nlm.nih.gov/pubmed/30959752
http://dx.doi.org/10.3390/ph12020052
work_keys_str_mv AT alshaerdanah 2018fdatidesharvest
AT almusaimiothman 2018fdatidesharvest
AT albericiofernando 2018fdatidesharvest
AT delatorrebeatrizg 2018fdatidesharvest

Ejemplares similares